In this episode of Denatured, sponsored by SK Pharmteco, Jennifer Smith-Parker speaks to Arvind Singh, vice president and global head of supply chain. In this episode, we discuss how CDMOs are revamping supply‑chain strategy for a new generation of intricate modalities. Topics addressed include moving from smarter raw‑material sourcing and precision cold‑chain logistics to navigating geopolitical and regulatory uncertainty and deploying AI to building sustainable, scalable capabilities from clinical through commercial.This episode is presented in partnership with <a rel="noopener noreferrer nofollow" href="https://www.skpharmteco.com/" target="_blank">SK Pharmteco</a>. Host<a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/jennifersmithparker/" target="_blank">Jennifer Smith-Parker</a>, Director of Insights, BioSpaceGuest<a rel="noopener noreferrer nofollow" href="https://www.linkedin.com/in/arvindsingh02/" target="_blank">Arvind Singh</a>, VP &amp; Global Head of Supply ChainDisclaimer: The views expressed in this discussion by guests are their own and do not represent those of their organizations.

FDA hears input on psychedelics, PDUFA, lung cancer’s next-gen therapies boost survival

Unravel the business of science with BioSpace. We dive into biopharma's top stories and biggest challenges, whether it’s layoffs, pipeline shake-ups, acquisitions, new FDA approvals or how to regulate AI in drug development.